Regeneron Pharmaceuticals (REGN) Net Margin (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Net Margin came in at 20.17% in Q1 2026, down 653.0% year-on-year from 3.65% in Q1 2025, and down 7.24% quarter-over-quarter from 21.74% in Q4 2025.
Regeneron Pharmaceuticals has reported Net Margin for 18 years, with the latest figure at 20.17% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 653.0% year-over-year to 20.17%; the trailing twelve-month figure through Mar 2026 stood at 29.65% (down 229.0% YoY), and the FY2025 full-year result was 31.41%, up 34.0% from the prior year.
- Net Margin for Q1 2026 stood at 20.17%, down from 21.74% in the prior quarter.
- The five-year high for Net Margin was 1947.0% in Q1 2022, with the low at 20.17% in Q1 2026.
- Average Net Margin over 5 years is 212.23%, with a median of 30.66% recorded in 2023.
- Year-over-year, Net Margin surged 190290 bps in 2022 and tumbled 192114 bps in 2023.
- Tracing REGN's Net Margin over 5 years: stood at 1197.1% in 2022, then tumbled by 97 bps to 33.77% in 2023, then declined by 28 bps to 24.22% in 2024, then slipped by 10 bps to 21.74% in 2025, then declined by 7 bps to 20.17% in 2026.
- The last three Net Margin figures came in at 20.17% (Q1 2026), 21.74% (Q4 2025), and 38.89% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.17% |
| Dec 31, 2025 | 21.74% |
| Sep 30, 2025 | 38.89% |
| Jun 30, 2025 | 37.86% |
| Mar 31, 2025 | 26.70% |
| Dec 31, 2024 | 24.22% |
| Sep 30, 2024 | 36.03% |
| Jun 30, 2024 | 40.38% |
| Mar 31, 2024 | 22.96% |
| Dec 31, 2023 | 33.77% |
| Sep 30, 2023 | 29.97% |
| Jun 30, 2023 | 30.66% |
| Mar 31, 2023 | 25.86% |
| Dec 31, 2022 | 1,197.10% |
| Sep 30, 2022 | 44.81% |
| Jun 30, 2022 | 29.82% |
| Mar 31, 2022 | 1,947.00% |
| Dec 31, 2021 | 45.01% |
| Sep 30, 2021 | 47.27% |
| Jun 30, 2021 | 60.31% |
| Mar 31, 2021 | 44.10% |
| Dec 31, 2020 | 47.43% |
| Sep 30, 2020 | 36.71% |
| Jun 30, 2020 | 45.97% |
| Mar 31, 2020 | 34.16% |
| Dec 31, 2019 | 42.50% |
| Sep 30, 2019 | 38.40% |
| Jun 30, 2019 | 12.24% |
| Mar 31, 2019 | 33.59% |
| Dec 31, 2018 | 42.56% |
| Sep 30, 2018 | 35.75% |
| Jun 30, 2018 | 34.29% |
| Mar 31, 2018 | 31.62% |
| Dec 31, 2017 | 10.96% |
| Sep 30, 2017 | 25.88% |
| Jun 30, 2017 | 26.38% |
| Mar 31, 2017 | 18.87% |
| Dec 31, 2016 | 20.63% |
| Sep 30, 2016 | 21.70% |
| Jun 30, 2016 | 16.18% |
| Mar 31, 2016 | 15.10% |
| Dec 31, 2015 | 14.12% |
| Sep 30, 2015 | 18.50% |
| Jun 30, 2015 | 19.49% |
| Mar 31, 2015 | 8.74% |
| Dec 31, 2014 | -17.78% |
| Sep 30, 2014 | 11.49% |
| Jun 30, 2014 | 14.47% |
| Mar 31, 2014 | 10.92% |
| Dec 31, 2013 | 14.12% |
| Sep 30, 2013 | 23.67% |
| Jun 30, 2013 | 19.09% |
| Mar 31, 2013 | 22.49% |
| Dec 31, 2012 | 113.45% |
| Sep 30, 2012 | 44.77% |
| Jun 30, 2012 | 25.21% |
| Mar 31, 2012 | 5.03% |
| Dec 31, 2011 | -43.46% |
| Sep 30, 2011 | -60.65% |
| Jun 30, 2011 | -57.98% |
| Mar 31, 2011 | -38.72% |
| Dec 31, 2010 | 111.94% |
| Sep 30, 2010 | -686.28% |
| Jun 30, 2010 | -21.98% |
| Mar 31, 2010 | -1,618.35% |
| Dec 31, 2009 | -309.18% |
| Sep 30, 2009 | -0.86% |
| Jun 30, 2009 | -331.96% |